Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glaukos (GKOS) Shares Issued (2016 - 2025)

Glaukos (GKOS) has disclosed Shares Issued for 12 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued changed N/A to $2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.5 million, a 81.41% increase, with the full-year FY2025 number at $13.5 million, up 81.41% from a year prior.
  • Shares Issued was $2.9 million for Q4 2025 at Glaukos, down from $7.6 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $22.8 million in Q3 2021 to a low of -$19.6 million in Q4 2021.
  • A 5-year average of $2.2 million and a median of $1.8 million in 2022 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 1332.33% in 2024; the steepest drop was 471.76% in 2024.
  • Glaukos' Shares Issued stood at -$19.6 million in 2021, then surged by 114.1% to $2.8 million in 2022, then plummeted by 112.54% to -$346000.0 in 2023, then tumbled by 4693.06% to -$16.6 million in 2024, then skyrocketed by 117.58% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for GKOS's Shares Issued are $2.9 million (Q4 2025), $7.6 million (Q3 2025), and -$1.1 million (Q2 2025).